Home › Borstkanker › Tennessee › Memphis
Borstkanker klinische studies in Memphis, TN
22 studies voor Borstkanker zoeken deelnemers op locaties in en rond Memphis (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RekruterenFase 1/2
- The West Cancer Center, Memphis
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekruterenFase 1/2
- Baptist Cancer Center - Memphis, Memphis
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruterenFase 3
- Baptist Memorial Healthcare, Memphis
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
RekruterenFase 2
- West Cancer Center, Germantown · 14 mijl verwijderd
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- West Cancer Center, Germantown · 14 mijl verwijderd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Bartlett · 11 mijl verwijderd
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- The West Clinic, P.C. dba West Cancer Center, Germantown · 14 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Baptist Cancer Center, Memphis
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekruterenFase 1/2
- The West Clinic, Germantown · 14 mijl verwijderd
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Rekruteren
- The West Clinic, PC dba West Cancer Center, Germantown · 14 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- West Cancer Center, Germantown · 14 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mijl verwijderd
- The West Clinic - Wolf River, Germantown · 14 mijl verwijderd
- en nog 1
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mijl verwijderd
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mijl verwijderd
Familial Investigations of Childhood Cancer Predisposition
RekruterenObservatieonderzoek
- St. Jude Children's Research Hospital, Memphis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mijl verwijderd
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 mijl verwijderd
- en nog 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Memphis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruterenFase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #11, Germantown · 14 mijl verwijderd
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- West Cancer Center, Germantown · 14 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Memphis
- Kanker (alle vormen)31 studies
- Niet-kleincellige longkanker23 studies
- Longkanker18 studies
- Sikkelcelziekte18 studies
- Acute lymfoblastaire leukemie16 studies
- Acute myeloïde leukemie15 studies
- Hartfalen13 studies
- Wekedel sarcoom11 studies
- Melanoom11 studies
- Prostaatkanker11 studies
- Colorectale kanker11 studies
- Osteosarcoom10 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.